Literature DB >> 17008270

The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.

Luciano G Nardo1, Priya Cheema, Tarek A Gelbaya, Greg Horne, Cheryl T Fitzgerald, Elizabeth H E Pease, Daniel R Brison, Brian A Lieberman.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious and potentially life-threatening complication following ovarian stimulation for in vitro fertilization (IVF). Coasting is the practice whereby the gonadotrophins are withheld and the administration of human chorionic gonadotrophin (hCG) is delayed until serum oestradiol (E2) has decreased to what is considered to be a safe level, to prevent the onset of OHSS. This study aimed to assess the length of coasting on the reproductive outcome in women at risk of developing OHSS. Coasting was undertaken when the serum E2 concentrations were > or = 17000 pmol/L but < 21000 pmol/L. Daily E2 measurements were performed and hCG was administered when hormone levels decreased to < 17000 pmol/L. Eighty-one women who had their stimulation cycles coasted were grouped according to the number of coasting days. Severe OHSS occurred in one case, which represented 1.2% of patients who underwent coasting because of an increased risk of developing the syndrome. No difference was found between cycles coasted for 1 - 3 days and cycles coasted for > or = 4 days in terms of oocyte maturity, fertilization and embryo cleavage rates. Women in whom coasting lasted for > or = 4 days had significantly fewer oocytes retrieved (P < 0.05) and decreased implantation rate (P < 0.05) compared to those coasted for 1 - 3 days. Pregnancy rate/embryo transfer and live birth rate did not differ between groups. In conclusion, coasting appears to decrease the risk of OHSS without compromising the IVF cycle pregnancy outcome. Prolonged coasting is, however, associated with reduced implantation rates, perhaps due to the deleterious effects on the endometrium rather than the oocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008270     DOI: 10.1080/14647270600787575

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  15 in total

1.  Is Coasting Valuable in All Patients with Any Cause of Infertility?

Authors:  Tahereh Madani; Nadia Jahangiri; Poopak Eftekhari-Yazdi; Mahnaz Ashrafi; Mohammadreza Akhoond
Journal:  Oman Med J       Date:  2016-11

Review 2.  Ovarian hyperstimulation syndrome: pathophysiology and prevention.

Authors:  Carolina O Nastri; Rui A Ferriani; Isa A Rocha; Wellington P Martins
Journal:  J Assist Reprod Genet       Date:  2010-02-06       Impact factor: 3.412

3.  Low grade inflammation, as evidenced by basal high sensitivity CRP, is not correlated to outcome measures in IVF.

Authors:  Sarah Robinson; Phil Pemberton; Ian Laing; Luciano G Nardo
Journal:  J Assist Reprod Genet       Date:  2008-09-23       Impact factor: 3.412

4.  Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Authors:  Ya-Qin Wang; Jin Luo; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jin Yang
Journal:  J Ovarian Res       Date:  2015-09-23       Impact factor: 4.234

5.  Ovarian hyperstimulation syndrome.

Authors:  Pratap Kumar; Sameer Farouk Sait; Alok Sharma; Mukesh Kumar
Journal:  J Hum Reprod Sci       Date:  2011-05

6.  Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.

Authors:  Srisailesh Vitthala; Jerome Bouaziz; Amanda Tozer; Ariel Zosmer; Talha Al-Shawaf
Journal:  Int J Endocrinol       Date:  2012-02-12       Impact factor: 3.257

7.  Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?

Authors:  Ömer Hamid Yumuşak; Serkan Kahyaoğlu; Ayşe Seval Özgü Erdinç; Saynur Yılmaz; Yaprak Engin Üstün; Nafiye Yılmaz
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

Review 8.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

9.  Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology.

Authors:  Deepika Pratap; Pratap Kumar; Satish Kumar Adiga
Journal:  J Hum Reprod Sci       Date:  2014-04

10.  GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial.

Authors:  Usama M Fouda; Ahmed M Sayed; Hesham S Elshaer; Bahaa Eldin M Hammad; Mona M Shaban; Khaled A Elsetohy; Mohamed A Youssef
Journal:  J Ovarian Res       Date:  2016-05-17       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.